Israel Englander’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,900
Closed -$499K 6274
2025
Q2
$499K Buy
+1,900
New +$463K ﹤0.01% 4913
2025
Q1
Sell
-900
Closed -$206K 6164
2024
Q4
$206K Sell
900
-9,600
-91% -$2.2M ﹤0.01% 5290
2024
Q3
$2.35M Sell
10,500
-69,500
-87% -$15.3M ﹤0.01% 3559
2024
Q2
$16.3M Buy
80,000
+17,900
+29% +$3.64M 0.01% 1669
2024
Q1
$13.6M Buy
62,100
+33,000
+113% +$7.27M 0.01% 1901
2023
Q4
$6.61M Buy
29,100
+14,500
+99% +$3.05M ﹤0.01% 2548
2023
Q3
$2.94M Buy
14,600
+2,727
+23% +$575K ﹤0.01% 3212
2023
Q2
$2.46M Buy
+11,873
New +$2.3M ﹤0.01% 3296
2023
Q1
Sell
-40,740
Closed -$8.24M 6629
2022
Q4
$8.24M Buy
+40,740
New +$7.96M ﹤0.01% 2339
2022
Q3
Sell
-18,624
Closed -$3.75M 7311
2022
Q2
$3.75M Buy
+18,624
New +$3.97M ﹤0.01% 3090
2022
Q1
Sell
-11,640
Closed -$3.14M 7220
2021
Q4
$3.14M Sell
11,640
-40,740
-78% -$10.1M ﹤0.01% 3333
2021
Q3
$12.7M Buy
52,380
+29,100
+125% +$7.33M 0.01% 1773
2021
Q2
$5.52M Sell
23,280
-40,740
-64% -$9.28M ﹤0.01% 2627
2021
Q1
$14M Buy
64,020
+51,449
+409% +$10.3M 0.01% 1433
2020
Q4
$2.2M Buy
+12,571
New +$2.17M ﹤0.01% 3167
2020
Q1
Sell
-87,300
Closed -$12.7M 4206
2019
Q4
$12.7M Buy
+87,300
New +$12.6M 0.02% 1183
2019
Q2
Sell
-46,560
Closed -$6.12M 4280
2019
Q1
$6.12M Buy
+46,560
New +$5.74M 0.01% 1616
2014
Q2
Sell
-18,158
Closed -$1.53M 3670
2014
Q1
$1.53M Sell
18,158
-15,132
-45% -$1.21M ﹤0.01% 1963
2013
Q4
$2.61M Buy
+33,290
New +$2.84M 0.01% 1630

Other funds holding LH

Israel Englander's LH Position: Q2 2026 in Review

Israel Englander increased its Labcorp (LH) stake by 83% in Q2 2026, buying an estimated $27.2M and bringing the position to 228,043 shares worth $63.9M. The position accounts for 0.02% of the portfolio, ranked #745.

Israel Englander first reported a position in LH in Q3 2013 and has held it in 52 quarters since. The position peaked at $280M in Q4 2021. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Israel Englander held 228,043 shares of Labcorp worth $63.9M as of Q2 2026.
  • Israel Englander bought 103,470 Labcorp shares in Q2 2026, an estimated $27.2M.
  • Labcorp made up 0.02% of Israel Englander's portfolio in Q2 2026, its #745 holding.
  • Israel Englander first reported a position in Labcorp in Q3 2013 and has held it in 52 quarters since.
  • Israel Englander's Labcorp position peaked at $280M in Q4 2021.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.